Liyun Gu

Title: Liyun Gu: Innovator in Biopharmaceuticals

Introduction

Liyun Gu is a prominent inventor based in Nanjing, China. She has made significant contributions to the field of biopharmaceuticals, particularly in the development of innovative treatments for tumors and viral infections. Her work is characterized by a strong focus on fusion proteins and their applications in medicine.

Latest Patents

Liyun Gu holds 1 patent for a fusion protein and its application in preparing medicine for treating tumors and/or viral infections. The patent describes a fusion protein that includes an antibody or antigen-binding fragment that specifically binds to human OX40 and a human interferon. This innovative approach aims to enhance the efficacy of pharmaceutical compositions in treating serious health conditions.

Career Highlights

Liyun Gu is currently associated with Nanjing Umab-biopharma Co., Ltd., where she continues to advance her research and development efforts. Her work at the company has positioned her as a key player in the biopharmaceutical industry, contributing to the development of novel therapeutic solutions.

Collaborations

Liyun collaborates with talented professionals in her field, including Shifu Mo and Yong Zhao. These partnerships enhance her research capabilities and foster innovation within her projects.

Conclusion

Liyun Gu's contributions to biopharmaceuticals, particularly through her patent on fusion proteins, highlight her role as an influential inventor in the medical field. Her ongoing work promises to lead to significant advancements in the treatment of tumors and viral infections.